The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Isoflurane, sold under the trade name Forane among others, is a general anesthetic。It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The global Isoflurane market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Isoflurane include Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., Pfizer, Indofine Chemical Company, Inc., Medicon Lifesciences and Rewine Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Isoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoflurane.
Report Scope
The Isoflurane market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Critical Care(Piramal Group)
Halocarbon
Aesica(Consort Medical Group)
Lunan Pharmaceutical Group
Shandong Keyuan Pharmaceutical Co., Ltd.
Pfizer
Indofine Chemical Company, Inc.
Medicon Lifesciences
Rewine Pharmaceutical
Segment by Type
Human Series
Animal Series
Segment by Application
Hospitals
Other Medical Institutions
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Isoflurane manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Isoflurane by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Isoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Isoflurane, sold under the trade name Forane among others, is a general anesthetic。It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The global Isoflurane market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Isoflurane include Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., Pfizer, Indofine Chemical Company, Inc., Medicon Lifesciences and Rewine Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Isoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoflurane.
Report Scope
The Isoflurane market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Critical Care(Piramal Group)
Halocarbon
Aesica(Consort Medical Group)
Lunan Pharmaceutical Group
Shandong Keyuan Pharmaceutical Co., Ltd.
Pfizer
Indofine Chemical Company, Inc.
Medicon Lifesciences
Rewine Pharmaceutical
Segment by Type
Human Series
Animal Series
Segment by Application
Hospitals
Other Medical Institutions
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Isoflurane manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Isoflurane by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Isoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Isoflurane Market Overview
1.1 Product Definition
1.2 Isoflurane Segment by Type
1.2.1 Global Isoflurane Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Human Series
1.2.3 Animal Series
1.3 Isoflurane Segment by Application
1.3.1 Global Isoflurane Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Hospitals
1.3.3 Other Medical Institutions
1.4 Global Market Growth Prospects
1.4.1 Global Isoflurane Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Isoflurane Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Isoflurane Production Estimates and Forecasts (2019-2030)
1.4.4 Global Isoflurane Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Isoflurane Production Market Share by Manufacturers (2019-2024)
2.2 Global Isoflurane Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Isoflurane, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Isoflurane Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Isoflurane, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Isoflurane, Product Offered and Application
2.8 Global Key Manufacturers of Isoflurane, Date of Enter into This Industry
2.9 Isoflurane Market Competitive Situation and Trends
2.9.1 Isoflurane Market Concentration Rate
2.9.2 Global 5 and 10 Largest Isoflurane Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Isoflurane Production by Region
3.1 Global Isoflurane Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Isoflurane Production Value by Region (2019-2030)
3.2.1 Global Isoflurane Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Isoflurane by Region (2025-2030)
3.3 Global Isoflurane Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Isoflurane Production by Region (2019-2030)
3.4.1 Global Isoflurane Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Isoflurane by Region (2025-2030)
3.5 Global Isoflurane Market Price Analysis by Region (2019-2024)
3.6 Global Isoflurane Production and Value, Year-over-Year Growth
3.6.1 North America Isoflurane Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Isoflurane Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Isoflurane Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Isoflurane Production Value Estimates and Forecasts (2019-2030)
4 Isoflurane Consumption by Region
4.1 Global Isoflurane Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Isoflurane Consumption by Region (2019-2030)
4.2.1 Global Isoflurane Consumption by Region (2019-2024)
4.2.2 Global Isoflurane Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Isoflurane Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Isoflurane Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Isoflurane Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Isoflurane Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Isoflurane Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Isoflurane Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Isoflurane Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Isoflurane Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Isoflurane Production by Type (2019-2030)
5.1.1 Global Isoflurane Production by Type (2019-2024)
5.1.2 Global Isoflurane Production by Type (2025-2030)
5.1.3 Global Isoflurane Production Market Share by Type (2019-2030)
5.2 Global Isoflurane Production Value by Type (2019-2030)
5.2.1 Global Isoflurane Production Value by Type (2019-2024)
5.2.2 Global Isoflurane Production Value by Type (2025-2030)
5.2.3 Global Isoflurane Production Value Market Share by Type (2019-2030)
5.3 Global Isoflurane Price by Type (2019-2030)
6 Segment by Application
6.1 Global Isoflurane Production by Application (2019-2030)
6.1.1 Global Isoflurane Production by Application (2019-2024)
6.1.2 Global Isoflurane Production by Application (2025-2030)
6.1.3 Global Isoflurane Production Market Share by Application (2019-2030)
6.2 Global Isoflurane Production Value by Application (2019-2030)
6.2.1 Global Isoflurane Production Value by Application (2019-2024)
6.2.2 Global Isoflurane Production Value by Application (2025-2030)
6.2.3 Global Isoflurane Production Value Market Share by Application (2019-2030)
6.3 Global Isoflurane Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Piramal Critical Care(Piramal Group)
7.1.1 Piramal Critical Care(Piramal Group) Isoflurane Corporation Information
7.1.2 Piramal Critical Care(Piramal Group) Isoflurane Product Portfolio
7.1.3 Piramal Critical Care(Piramal Group) Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Piramal Critical Care(Piramal Group) Main Business and Markets Served
7.1.5 Piramal Critical Care(Piramal Group) Recent Developments/Updates
7.2 Halocarbon
7.2.1 Halocarbon Isoflurane Corporation Information
7.2.2 Halocarbon Isoflurane Product Portfolio
7.2.3 Halocarbon Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Halocarbon Main Business and Markets Served
7.2.5 Halocarbon Recent Developments/Updates
7.3 Aesica(Consort Medical Group)
7.3.1 Aesica(Consort Medical Group) Isoflurane Corporation Information
7.3.2 Aesica(Consort Medical Group) Isoflurane Product Portfolio
7.3.3 Aesica(Consort Medical Group) Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Aesica(Consort Medical Group) Main Business and Markets Served
7.3.5 Aesica(Consort Medical Group) Recent Developments/Updates
7.4 Lunan Pharmaceutical Group
7.4.1 Lunan Pharmaceutical Group Isoflurane Corporation Information
7.4.2 Lunan Pharmaceutical Group Isoflurane Product Portfolio
7.4.3 Lunan Pharmaceutical Group Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Lunan Pharmaceutical Group Main Business and Markets Served
7.4.5 Lunan Pharmaceutical Group Recent Developments/Updates
7.5 Shandong Keyuan Pharmaceutical Co., Ltd.
7.5.1 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Corporation Information
7.5.2 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Product Portfolio
7.5.3 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Shandong Keyuan Pharmaceutical Co., Ltd. Main Business and Markets Served
7.5.5 Shandong Keyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
7.6 Pfizer
7.6.1 Pfizer Isoflurane Corporation Information
7.6.2 Pfizer Isoflurane Product Portfolio
7.6.3 Pfizer Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Pfizer Main Business and Markets Served
7.6.5 Pfizer Recent Developments/Updates
7.7 Indofine Chemical Company, Inc.
7.7.1 Indofine Chemical Company, Inc. Isoflurane Corporation Information
7.7.2 Indofine Chemical Company, Inc. Isoflurane Product Portfolio
7.7.3 Indofine Chemical Company, Inc. Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Indofine Chemical Company, Inc. Main Business and Markets Served
7.7.5 Indofine Chemical Company, Inc. Recent Developments/Updates
7.8 Medicon Lifesciences
7.8.1 Medicon Lifesciences Isoflurane Corporation Information
7.8.2 Medicon Lifesciences Isoflurane Product Portfolio
7.8.3 Medicon Lifesciences Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Medicon Lifesciences Main Business and Markets Served
7.7.5 Medicon Lifesciences Recent Developments/Updates
7.9 Rewine Pharmaceutical
7.9.1 Rewine Pharmaceutical Isoflurane Corporation Information
7.9.2 Rewine Pharmaceutical Isoflurane Product Portfolio
7.9.3 Rewine Pharmaceutical Isoflurane Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Rewine Pharmaceutical Main Business and Markets Served
7.9.5 Rewine Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Isoflurane Industry Chain Analysis
8.2 Isoflurane Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Isoflurane Production Mode & Process
8.4 Isoflurane Sales and Marketing
8.4.1 Isoflurane Sales Channels
8.4.2 Isoflurane Distributors
8.5 Isoflurane Customers
9 Isoflurane Market Dynamics
9.1 Isoflurane Industry Trends
9.2 Isoflurane Market Drivers
9.3 Isoflurane Market Challenges
9.4 Isoflurane Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
